Omnicom Group Inc. (OMC)
NYSE: OMC
· Real-Time Price · USD
70.42
-3.02 (-4.11%)
At close: Jun 02, 2025, 3:59 PM
70.31
-0.16%
After-hours: Jun 02, 2025, 07:56 PM EDT
Omnicom Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Advertising Revenue | 8.47B | 7.89B | 7.42B | 7.96B | 7.37B | 8.45B |
| Advertising Revenue Growth | +7.29% | +6.28% | -6.72% | +8.01% | -12.81% | n/a |
| Experiential Revenue | 731.5M | 651.4M | 645.5M | 1.26B | 1.3B | 1.38B |
| Experiential Revenue Growth | +12.30% | +0.91% | -48.79% | -3.18% | -5.59% | n/a |
| Health Care Revenue | 1.35B | 1.36B | 1.32B | 1.39B | n/a | n/a |
| Health Care Revenue Growth | -0.59% | +3.49% | -5.38% | n/a | n/a | n/a |
| Public relations Revenue | 1.68B | 1.58B | 1.55B | n/a | n/a | n/a |
| Public relations Revenue Growth | +6.35% | +2.14% | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific Revenue | 1.85B | 1.78B | 1.75B | 1.8B | 1.5B | 1.65B | 8B | 1.65B | 1.64B | 1.57B | 1.6B | 1.58B | 1.56B | 4.49B |
| Asia Pacific Revenue Growth | +3.89% | +1.77% | -2.76% | +19.47% | -8.84% | -79.38% | +384.75% | +0.86% | +4.09% | -1.91% | +1.42% | +1.37% | -65.30% | n/a |
| Emea Revenue | 4.44B | 4.27B | 4.01B | 296.1M | 275.4M | 403.4M | n/a | 4.44B | 4.18B | 4.2B | 4.59B | 4.41B | 4.29B | n/a |
| Emea Revenue Growth | +4.03% | +6.39% | +1254.44% | +7.52% | -31.73% | n/a | n/a | +6.20% | -0.49% | -8.50% | +4.23% | +2.86% | n/a | n/a |
| Latin America Revenue | 433.7M | 386.8M | 329M | 267.6M | 207.2M | 314.6M | n/a | 8.2B | 8.63B | 8.53B | 8.15B | n/a | n/a | n/a |
| Latin America Revenue Growth | +12.13% | +17.57% | +22.94% | +29.15% | -34.14% | n/a | n/a | -4.99% | +1.19% | +4.59% | n/a | n/a | n/a | n/a |
| Middle East And Africa Revenue | 319.2M | 309.6M | 346.7M | 7.71B | 7.58B | 8.48B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Middle East And Africa Revenue Growth | +3.10% | -10.70% | -95.50% | +1.75% | -10.63% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| North America Revenue | 8.65B | 7.95B | 7.86B | 7.25B | 7.19B | 8.03B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| North America Revenue Growth | +8.79% | +1.21% | +8.42% | +0.83% | -10.54% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 8.19B | 7.47B | 7.37B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +9.57% | +1.42% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 117.9M | 112.3M | 99.5M | 111M | 85.3M | 115.6M | 89.8M | 99.1M | 89.2M | 84.5M | 86.4M | 110.9M | 96.7M | 109.9M | 95M | 103.2M | 71.6M | 101.4M | 90.2M | 82.1M | 86.8M | 97.5M | 97.2M | 107.7M | 103.6M | 119M | 113.5M | 117.4M | 105.4M | 121.5M | 99.5M | 120.4M | 108.6M | 120.8M | 104.1M | 110.9M | 3.08B | 459M | 445.7M | 477M | 470.7M |
| Selling, General, and Administrative Revenue Growth | +4.99% | +12.86% | -10.36% | +30.13% | -26.21% | +28.73% | -9.38% | +11.10% | +5.56% | -2.20% | -22.09% | +14.68% | -12.01% | +15.68% | -7.95% | +44.13% | -29.39% | +12.42% | +9.87% | -5.41% | -10.97% | +0.31% | -9.75% | +3.96% | -12.94% | +4.85% | -3.32% | +11.39% | -13.25% | +22.11% | -17.36% | +10.87% | -10.10% | +16.04% | -6.13% | -96.40% | +570.74% | +2.98% | -6.56% | +1.34% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |